Summarized quarterly financial data for fiscal years 2020 and 2019 is as follows (Details) - USD ($)	3 Months Ended												12 Months Ended
	Dec. 31, 2020		Sep. 30, 2020		Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019		Jun. 30, 2019		Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Aug. 05, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Revenues	$ 22,577,000	[1]	$ 19,343,000	[2],[3],[4],[5]	$ 10,701,000	$ 12,251,000	$ 15,902,000	$ 23,719,000	[6]	$ 6,079,000	[7]	$ 3,947,000	$ 64,872,280	$ 49,646,937	$ 16,099,460
Gross profit	16,996,000	[1]	16,064,000	[2],[3],[4],[5]	6,301,000	9,536,000	13,023,000	22,275,000	[6]	4,830,000	[7]	3,184,000	48,897,303	43,312,352	13,361,808
Net loss	$ (42,088,000)	[1]	$ (32,611,000)	[2],[3],[4],[5]	$ (51,976,000)	$ (56,849,000)	$ (49,435,000)	$ (31,967,000)	[6]	$ (55,237,000)	[7]	$ (39,506,000)	$ (183,524,137)	$ (176,144,999)	$ (132,617,160)
Loss per common share, basic and diluted	$ (0.15)	[1]	$ (0.12)	[2],[3],[4],[5]	$ (0.19)	$ (0.21)	$ (0.19)	$ (0.13)	[6]	$ (0.23)	[7]	$ (0.16)	$ (0.67)	$ (0.72)	$ (0.59)
Write off of patent and trademark cost	$ 500,000		$ 600,000										$ 1,131,776	$ 78,864
Inventory charge			5,700,000										7,204,818	0
Loss on extinguishment of debt										$ 10,100,000				$ 10,057,632
Lender Warrants [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Fair value of warrants			7,400,000													$ 7,428,178
Knight License Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Revenues			$ 2,000,000
License Agreement Theramex [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Revenues								$ 1,500,000

[1] During the fourth quarter of 2020, we wrote off approximately $0.5 million in costs related to trademarks and patents. Refer to discussion in Note 6-Intangible Assets, Net.

[2] During the third quarter of 2020, we recorded $2 million in license revenue related to the Knight License Agreement. Refer to discussion in Note 2-Summary of Significant Accounting Policies.

[3] During the third quarter of 2020, we recorded approximately $5.7 million in inventory charge, primarily related to BIJUVA. Refer to discussion in Note 2-Summary of Significant Accounting Policies.

[4] During the third quarter of 2020, we recorded the fair value of the Lender Warrants based on Amendment No. 5 of approximately $7.4 million as a debt discount, which is being amortized to interest expense using the effective interest method over the term of the Financing Agreement. Refer to discussion in Note 8-Debt.

[5] During the third quarter of 2020, we wrote off approximately $0.6 million in costs related to trademarks and patents. Refer to discussion in Note 6-Intangible Assets, Net.

[6] During the third quarter of 2019, we recorded approximately $15.5 million in license revenue related to the Theramex License Agreement. Refer to discussion in Note 2-Summary of Significant Accounting Policies.

[7] During the second quarter of 2019, we recorded approximately $10.1 million in loss on extinguishment of debt related to the repayment of the Credit Agreement. Refer to discussion in Note 8-Debt.